logo

TCON(Delisted)

TRACONยทNASDAQ
--
--(--)

TCON Profile

Tracon Pharmaceuticals, Inc.

A clinical stage biopharmaceutical company that develops novel targeted therapeutics for cancer

--
10/28/2004
01/30/2015
NASDAQ Stock Exchange
17
12-31
Common stock
4350 La Jolla Village Drive , Suite 800 , San Diego, CA 92122
--
TRACON Pharmaceuticals, Inc., was incorporated in Delaware on October 28, 2004. The Company is a biopharmaceutical company focused on the development and commercialization of novel targeted therapies for cancer, and leverages a cost-effective, contract research organization (CRO) independent product development platform to collaborate with other life science companies to develop and commercialize innovative products in the United States.